Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 2/20 | 0.87 |
| ▸ | MAPT | P10636 | 7/20 | 0.73 |
| ▸ | POLB | P06746 | 5/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | GAA | P10253 | 3/20 | 0.73 |
| ▸ | RECQL | P46063 | 2/20 | 0.73 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.73 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.69 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.69 |
| ▸ | ALPL | P05186 | 1/20 | 0.69 |
| ▸ | ALPI | P09923 | 1/20 | 0.69 |
| ▸ | ALPG | P10696 | 1/20 | 0.69 |
| ▸ | PKM | P14618 | 1/20 | 0.69 |
| ▸ | APEX1 | P27695 | 1/20 | 0.69 |
| ▸ | BLM | P54132 | 1/20 | 0.69 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isothymusin SCHEMBL31483965 | 1.00 | PPARG (0.87) | PPARGMAPTPOLBKDM4EALDH1A1 | |
| Xanthomicrol SCHEMBL6257160 | 0.93 | PPARG (1.00) | PPARGMAPTPOLBKDM4EALDH1A1 | |
| SCHEMBL29974322 | 0.93 | PPARG (0.81) | PPARGMAPTPOLBKDM4EALDH1A1 | |
| SCHEMBL27221221 | 0.93 | PPARG (0.81) | PPARGMAPTPOLBKDM4EALDH1A1 | |
| SCHEMBL30683238 | 0.90 | PPARG (0.85) | PPARGMAPTPOLBKDM4EALDH1A1 | |
| SCHEMBL2180082 | 0.90 | PPARG (0.85) | PPARGMAPTPOLBKDM4EALDH1A1 | |
| SCHEMBL30213777 | 0.90 | PPARG (0.90) | PPARGMAPTPOLBKDM4EALDH1A1 | |
| SCHEMBL29449516 | 0.90 | ALDH1A1 (0.88) | PPARGMAPTPOLBKDM4EALDH1A1 | |
| SCHEMBL8160531 | 0.89 | ALDH1A1 (0.82) | PPARGMAPTPOLBKDM4EALDH1A1 | |
| SCHEMBL7554410 | 0.88 | PPARG (0.81) | PPARGMAPTPOLBKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100160244-A1 | METHODS AND COMPOSITIONS FOR ENHANCING COLLAGEN, PROTEOGLYCAN, AND GLUTATHIONE SYNTHESIS IN THE SKIN | NIMNI MARCEL | 2010-06-24 | — | — | US | claimed |
| US-20090053290-A1 | TRANSDERMAL DRUG DELIVERY COMPOSITIONS AND TOPICAL COMPOSITIONS FOR APPLICATION ON THE SKIN | NUVIANCE, INC. | 2009-02-26 | — | — | US | claimed |
| EP-1998742-A2 | TRANSDERMAL DRUG DELIVERY COMPOSITIONS AND TOPICAL COMPOSITIONS FOR APPLICATION ON THE SKIN | Nuviance, INC. (US) | 2008-12-10 | — | — | EP | claimed |
| WO-2007103555-A2 | TRANSDERMAL DRUG DELIVERY COMPOSITIONS AND TOPICAL COMPOSITIONS FOR APPLICATION ON THE SKIN | NUVIANCE, INC. (US) | 2007-09-13 | — | — | WO | claimed |
| US-20060067959-A1 | Compositions and methods for treatment of solar damage | NIMNI MARCEL | 2006-03-30 | — | — | US | claimed |
| US-20060045926-A1 | Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin | NIMNI MARCEL | 2006-03-02 | — | — | US | claimed |
| US-6576271-B2 | Using plant extract | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY | 2003-06-10 | — | — | US | claimed |
| US-11738084-B2 | Compositions for transfection of biomolecules into cells | SZATHMARY SUSAN (US) | 2023-08-29 | — | — | US | disclosed |
| EP-2421952-B1 | COMPOSITIONS FOR TRANSFECTION OF BIOMOLECULES INTO CELLS | GALEN BIO INC (US) | 2016-03-30 | — | — | EP | disclosed |
| EP-2421952-A2 | COMPOSITIONS FOR TRANSFECTION OF BIOMOLECULES INTO CELLS | Galen Bio, Inc. (US) | 2012-02-29 | — | — | EP | disclosed |
| WO-2010123798-A2 | COMPOSITIONS FOR TRANSFECTION OF BIOMOLECULES INTO CELLS | GALENBIO, INC. (US) | 2010-10-28 | — | — | WO | disclosed |
| US-20100160244-A1 | METHODS AND COMPOSITIONS FOR ENHANCING COLLAGEN, PROTEOGLYCAN, AND GLUTATHIONE SYNTHESIS IN THE SKIN | NIMNI MARCEL | 2010-06-24 | — | — | US | disclosed |
| US-7598291-B2 | Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin | NIMNI MARCEL | 2009-10-06 | — | — | US | disclosed |
| US-6576271-B2 | Using plant extract | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY | 2003-06-10 | — | — | US | disclosed |
| EP-1137429-A2 | BIOFLAVONOIDS, ANTHOCYANINS AND PHENOLIC COMPOUNDS FROM CHERRIES FOR INHIBITING INFLAMMATION | MICHIGAN STATE UNIVERSITY (US) | 2001-10-04 | — | — | EP | disclosed |
| US-20010020009-A1 | Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY (US) | 2001-09-06 | — | — | US | disclosed |
| US-20010002407-A1 | Method for inhibiting cyclooxygenase and inflammation using cyanidin | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY (US) | 2001-05-31 | — | — | US | disclosed |
| US-6194469-B1 | INHIBITING CYCLOOXYGENASE OR PROSTOGLANDIN H SYNTHASE ENZYMES BY PROVIDING AN ANTHOCYANIN ISOLATED FROM CHERRY FRUIT SELECTED FROM CYANIDIN-3-GLUCOSYLRUTINOSIDE, CYANIDIN-3-RUTINOSIDE OR CYANIDIN-3-GLUCOSIDE | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERISTY | 2001-02-27 | — | — | US | disclosed |
| WO-2000033824-A2 | BIOFLAVONOIDS, ANTHOCYANINS AND PHENOLIC COMPOUNDS FROM CHERRIES FOR INHIBITING INFLAMMATION | MICHIGAN STATE UNIVERSITY (US) | 2000-06-15 | — | — | WO | disclosed |
| WO-2000033667-A2 | BIOFLAVONOIDS, ANTHOCYANINS AND PHENOL COMPOUNDS FROM CHERRIES AS ANTIOXIDANTS | MICHIGAN STATE UNIVERSITY (US) | 2000-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060045926-A1 | Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin | COL1A1, COL14A1, COL2A1 | PPARG 83/4885MAPT 3935/4885POLB 1108/4885 |
| US-20100160244-A1 | METHODS AND COMPOSITIONS FOR ENHANCING COLLAGEN, PROTEOGLYCAN, AND GLUTATHIONE SYNTHESIS IN THE SKIN | CUTA, COL14A1, COL2A1 | PPARG 329/4885MAPT 2821/4885POLB 1344/4885 |
| US-20090053290-A1 | TRANSDERMAL DRUG DELIVERY COMPOSITIONS AND TOPICAL COMPOSITIONS FOR APPLICATION ON THE SKIN | LRAT, LTA, COLGALT1 | PPARG 367/4885MAPT 373/4885POLB 3696/4885 |
| US-20060067959-A1 | Compositions and methods for treatment of solar damage | AAAS, LRRK2, CSTB | PPARG 4278/4885MAPT 119/4885POLB 620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.